ATACA ATİLLA, P. Et Al. 2018. Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea. HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY , vol.11, no.1 , 13-17.

ATACA ATİLLA, P., ATİLLA, E., CİVRİZ BOZDAĞ, S., YÜKSEL, M., TOPRAK, S. K., TOPÇUOĞLU, P., ... DEMİRER, T.(2018). Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea. HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY , vol.11, no.1, 13-17.

ATACA ATİLLA, PINAR Et Al. "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea," HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY , vol.11, no.1, 13-17, 2018

ATACA ATİLLA, PINAR A. Et Al. "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea." HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY , vol.11, no.1, pp.13-17, 2018

ATACA ATİLLA, P. Et Al. (2018) . "Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea." HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY , vol.11, no.1, pp.13-17.

@article{article, author={PINAR ATACA ATİLLA Et Al. }, title={Treatment with methotrexate, rituximab, and cytosine arabinoside followed by autologous stem cell transplantation in primary central nervous system lymphoma: A single-center experiencea}, journal={HEMATOLOGY/ONCOLOGY AND STEM CELL THERAPY}, year=2018, pages={13-17} }